Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action

Table 1 Gender specific prevalence of type 2 diabetes in % (CI) in 20 Middle East and North Africa countries in 2000 and 2014 as reported by the World Health Organization[1] and for Palestine[144]

Country	2000		2014
	Men	Women	Men	Women
Afghanistan	8.1 (5.3-11.5)	8.5 (5.7-11.9)	11.6 (6.4-18.2)	12.2 (6.8-18.8)
Algeria	8.6 (6.0-11.8)	9.2 (6.5-12.3)	12.3 (7.4-18.8)	12.6 (7.7-18.9)
Bahrain	10.6 (7.6-14.2)	9.9 (7.1-13.5)	12.0 (7.0-18.5)	10.6 (6.1-16.7)
Egypt	10.8 (7.5-14.7)	13.3 (9.6-17.5)	16.0 (10.0-23.6)	19.8 (12.9-28.2)
Iran	7.4 (5.5-9.4)	8.5 (6.4-10.7)	11.4 (7.2-17.2)	12.9 (8.4-18.8)
Iraq	11.5 (8.2-15.4)	12.4 (9.1-16.2)	17.2 (10.7-25.3)	17.5 (11.1-25.4)
Jordan	12.0 (8.8-15.9)	14.0 (10.5-18.0)	16.5 (10.5-24.0)	17.2 (11.3-24.6)
Kuwait	15.3 (11.2-20.3)	15.6 (11.4-20.4)	19.7 (12.8-28.1)	19.6 (12.9-27.7)
Lebanon	9.0 (5.7-13.1)	8.4 (5.3-12.2)	14.5 (8.7-21.8)	12.2 (7.4-18.5)
Libya	10.7 (7.9-14.1)	12.2 (9.1-15.8)	15.2 (9.5-22.5)	16.6 (10.7-23.8)
Morocco	9.0 (6.2-12.4)	9.2 (6.4-12.6}	14.0 (8.4-21.5}	13.4 (8.1-20.5}
Oman	10.2 (7.6-13.6)	9.9 (7.3-13.1)	14.3 (8.6-21.7)	12.3 (7.4-18.4)
Pakistan	9.1 (6.3-12.2)	9.0 (6.3-12.2)	12.6 (7.0-19.5)	12.1 (7.0-18.6)
Palestine	10.6 (7.8-14.0)	11.8 (8.9-15.2)	16.5 (10.3-24.3)	17.5 (11.4-24.9)
Qatar	13.7 (9.9-18.1)	14.2 (10.4-18.5)	18.9 (12.0-27.0)	18.8 (12.2-26.8)
Saudi Arabia	13.1 (9.8-17.1)	13.1 (9.8-17.0)	17.6 (11.5-25.4)	17.0 (11.1-24.4)
Syria	9.8 (7.0-13.2)	10.9 (8.1-14.2)	14.0 (8.5-21.0)	15.3 (9.6-22.4)
Tunisia	8.3 (6.0-11.1)	9.7 (7.2-12.7)	12.1 (7.4-18.3)	12.9 (7.9-19.0)
United Arab Emirates	11.8 (8.6-16.0)	12.4 (9.1-16.5)	15.0 (9.2-22.5)	15.4 (9.7-22.6)
Yemen	7.4 (4.5-11.3)	6.2 (3.6-9.4)	12.6 (6.7-20.6)	10.1 (5.3-17.0)